Skip to main content

Verification & Compliance Record

Enforcement records
Full FDA/FTC/Health Canada enforcement-records search not yet performed for Invigor8 Rx, L.l.c..
Website reachable
The listed website responded to the most recent check.

PeptideBase reports publicly documented information for educational purposes. This is not medical or legal advice, and listing does not constitute endorsement.

Are you Invigor8 Rx, L.l.c.? Claim this listing to update your information and add verification.

Claim listing
503A Pharmacy
Verified listing

Verified

Invigor8 Rx, L.l.c.

Sugar Land, Texas, United States

No rating available

Invigor8 Rx is a licensed 503(a) pharmacy that compounds sterile pharmaceutical products, including peptides, injectable compounds, and specialized formulations for patients who need rare or out-of-stock medications. They offer medication consultations, sterile compounding services, and direct product sales through their online platform. The pharmacy serves patients seeking customized pharmaceutical solutions at competitive pricing.

Provider Details

503A Compounding Pharmacy

Prescriptions are required. Compounds are prepared to order for individual patients and cannot be sold in bulk without a physician order.

Coverage

Country
United States
State
Texas
Telehealth
Not available
Regions Served
United States

Compliance

Verified Listing
Yes
Compliance Type
503A Compounding

Verification & FDA Records

Verified listing· · 503A Compounding Pharmacy

Commercial relationships never influence ranking, verification status, or scoring. No paid placements or sponsored rankings exist in this directory.

Report an error

Invigor8 Rx, L.l.c.

Use this form to flag incorrect data, outdated information, or a misattributed finding. Our team reviews every report.

Related providers

Track this provider

Know when Invigor8 Rx, L.l.c. changes.

Get an email when their verification status, reviews, or peptide list is updated.

PeptideBase badge

Add this badge to your website

Profile last updated

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.